🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
30.20
-2.34 (-7.19%)
Nov 20, 2026, 4:00 PM EST - Market closed

Nektar Therapeutics Revenue

Nektar Therapeutics had revenue of $9.39M in the quarter ending September 30, 2026, a decrease of -20.39%. This brings the company's total for the last twelve months to $52.19M, down -16.64% year-over-year. In the year 2025, Nektar Therapeutics had annual revenue of $55.23M, down -43.89%. That makes Nektar Therapeutics the 27,724th largest company in the world by revenue and 3,747th in the United States.

Revenue (ttm)
$52.19M
Revenue Growth
-16.64%
P/S Ratio
19.80
Revenue / Employee
$828,333
Employees
63
Market Cap
1.03B

Revenue Chart

Revenue by Geography

  • Rest of World 97.05M 98.6%
  • United States 1.38M 1.4%
Fiscal year ended Dec 31, 2024 See the full Nektar Therapeutics breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202555.23M-43.20M-43.89%
Dec 31, 202498.43M8.31M9.22%
Dec 31, 202390.12M-1.93M-2.10%
Dec 31, 202292.06M-9.85M-9.67%
Dec 31, 2021101.91M-51.01M-33.36%
Dec 31, 2020152.92M38.30M33.41%
Dec 31, 2019114.62M-1.08B-90.40%
Dec 31, 20181.19B885.61M287.81%
Dec 31, 2017307.71M142.28M86.00%
Dec 31, 2016165.44M-65.35M-28.32%
Dec 31, 2015230.78M30.08M14.99%
Dec 31, 2014200.71M51.79M34.77%
Dec 31, 2013148.92M67.73M83.42%
Dec 31, 201281.19M9.71M13.59%
Dec 31, 201171.48M-87.56M-55.06%
Dec 31, 2010159.04M87.11M121.10%
Dec 31, 200971.93M-18.25M-20.24%
Dec 31, 200890.19M-182.84M-66.97%
Dec 31, 2007273.03M55.31M25.40%
Dec 31, 2006217.72M91.44M72.41%
Dec 31, 2005126.28M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.